Delivery Order SPE2DB24D1007-SPE2DB25FCBHU

Award Date 4/17/25
Potential Completion Date 5/8/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the medication Tagrisso 80 mg tablet, with a ceiling value of $10,662.57 and a period of performance through May 9, 2025. This is a delivery order contract with a firm fixed price pricing type. The contract is not set aside and is open to full and open competition. Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,641.07 firm fixed-price delivery order is for Tagrisso 40 mg tablets, with a performance period through January 28, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $10,662.57 fixed-price delivery order is for the drug Tagrisso, an 80 mg tablet product, with a period of performance through February 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $31,616.37 firm fixed-price contract is for the delivery of the prescription medication Tagrisso 80 mg tablets. The contract has an ultimate completion date of August 16, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $10,662.57 delivery order contract is for the supply of the pharmaceutical product Tagrisso 80 mg tablet 30s. The contract is a firm fixed-price, non-set-aside award with a completion date of June 11, 2025. Amerisourcebergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $31,987.71, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the medication Tagrisso 80 mg tablet, with an ultimate completion date of May 13, 2025. The contract is a firm fixed-price arrangement and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $21,016.64 firm fixed price delivery order is for the supply of Tagrisso 40 mg tablets, a prescription medication. The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,508.31, is a delivery order for the supply of TAGRISSO 40 MG TABLET 30S, a medical product. The contract has a completion date of January 29, 2024 and is a firm fixed-price arrangement. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,662.57 firm fixed-price contract is for the delivery of the prescription medication Tagrisso 80 mg tablets. The contract has an ultimate completion date of May 12, 2025 and is not set-aside. AmerisourceBergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,903.03, is for the delivery of the prescription medication Tagrisso 80 mg tablets. It is a firm fixed-price delivery order contract with a completion date of December 16, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
  • SPE2DB24D1007
    Indefinite Delivery Contract
  • SPE2DB24D1007-SPE2DB25FCBHU
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $10,641.07, is for the delivery of the prescription medication Tagrisso 40 mg tablets. The contract is a Firm Fixed Price Delivery Order, with a performance period through May 8, 2025. This award is not associated with a set-aside program and represents open competition. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs through December 2026. This delivery order is one of many such awards under that broader IDC, demonstrating Amerisourcebergen's role as a critical vendor supporting federal medical procurement needs, particularly for the military and veteran healthcare systems.

Generated 7/17/25, 2:29 PM